New Delhi (NVI): Amid the race to develop a potential Covid-19 vaccine in India, the Indian government today launched an online web portal for information and updates on the various Covid-19 vaccine being produced in the country, Union Health Minister Harsh Vardhan announced.
The online portal available on the Indian Council of Medical Research (ICMR) site, will be a repository for all information related to vaccine development in India.
“Everyone will be able to go online to that portal a look-up all contemporary research-development and clinical trials related information about such vaccinations,” said Vardhan during the press conference on ICMR’s 100-year timeline of history.
I congratulate @ICMRDELHI for developing 'Vaccine Web Portal' & 'National Clinical Registry for #Covid19'
The portal details Indian efforts towards developing #vaccines & the registry will collect quality real-time clinical data of #Covid19 patients.@PMOIndia @MoHFW_INDIA pic.twitter.com/rKlipBABQx
— Dr Harsh Vardhan (@drharshvardhan) September 28, 2020
In addition to this, Ministry of Health & Family Welfare, Indian Council of Medical Research (ICMR), and All India Institute of Medical Sciences (AIIMS) New Delhi also launched a National Clinical Registry for COVID-19.
The registry will aim at collecting good quality real time clinical data to inform evidence-based clinical practice, research, formulating guidelines and policy.
Vardhan during the press conference hailed ICMR’s efforts and contributions in the field of science.
“It’s an honour for me to release 100-year timeline of history of ICMR within its premises today. The contribution of scientists associated with it is commemorated and serves as an inspiration to upcoming scientists,” the minister added.
“The ICMR has always attempted to address itself to the growing demands of scientific advances in biomedical research on the one hand, and to the need of finding practical solutions to the health problems of the country, on the other,” the portal reads.
India is currently on different phases of clinical trials of three Covid-19 vaccines.
The phase-III or the last stage of clinical trial of the Covid-19 vaccine ‘Covishield’, being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began on Monday at the state-run Sassoon General Hospital in Pune, Maharashtra.
-CHK
